The Shift Toward Recognised Brands in Medical Cannabis

The Shift Toward Recognised Brands in Medical Cannabis

Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market evolves, established cannabis brands are playing an increasingly critical role in patient care, physician confidence, and regulatory acceptance, mirroring the progression of traditional pharmaceuticals. At SOMAÍ, we work with some of the most recognised cannabis b…